Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6490
    -0.0010 (-0.16%)
     

  • OIL

    82.31
    -0.50 (-0.60%)
     

  • GOLD

    2,327.70
    -10.70 (-0.46%)
     

  • Bitcoin AUD

    97,207.54
    -4,561.04 (-4.48%)
     

  • CMC Crypto 200

    1,345.37
    -37.20 (-2.69%)
     

  • AUD/EUR

    0.6070
    -0.0000 (-0.00%)
     

  • AUD/NZD

    1.0953
    +0.0012 (+0.11%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,056.52
    +16.14 (+0.20%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    17,887.95
    -200.75 (-1.11%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

US Nuclear’s Partner Grapheton Moves to Accelerate Product Development with Help of New CEO

US Nuclear Corp.
·2-min read

LOS ANGELES, CA, Oct. 25, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – US Nuclear’s (OTCQB: UCLE) partner Grapheton recently hired a new CEO, Terry Lingren, to accelerate product development by raising funds and allowing founder and CTO Sam Kassegne to focus on research and development.

Sam is the creative genius behind Grapheton’s glassy carbon supercapacitor technology that can benefit us all by speeding up EV chargers, augmenting or replacing EV onboard batteries, developing a new generation of computer chips with tiny supercapacitors, and advancing treatment of neurological diseases and brain, spinal, and prosthetic cases. Mr. Lingren has significant experience raising capital, growing profitable businesses, and bringing high-tech products to market-clearing the way for rapid product development at Grapheton. Sam and Grapheton are also assisted by a scientific advisory board of 5 prestigious members specializing in fields such as bioengineering, neural technology, rehabilitative technology and medicine, microfabrication, and commercializing cutting-edge technology.

Grapheton is in several emerging industries (brain-computer interface, neural probes and devices, supercapacitors for EV charging and computer chip applications) which are clear opportunities for investors. Looking forward, Grapheton expects to have a number of income streams from these emerging industries where its patents and disruptive high-tech products and services are highly needed.

https://grapheton.com/team/

ADVERTISEMENT

Safe Harbor Act

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com.

CONTACT:

US Nuclear Corp. (OTCQB: UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Rachel Boulds, Chief Financial Officer
(818) 883 7043
Email: info@usnuclearcorp.com
www.usnuclearcorp.com
www.tech-associates.com
www.overhoff.com